Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,cash,totalCurrentLiabilities,totalCurrentAssets,shortTermInvestments,accountsPayable,longTermInvestments,netReceivables,changeToLiabilities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,otherCashflowsFromFinancingActivities,changeToNetincome,investments,totalCashflowsFromInvestingActivities,netBorrowings,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,currency,shortName,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,exchangeDataDelayedBy,priceHint,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchange,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,KBPH,6326628.0,9801830,,,-4017,,-4017,91669,5,-332711,-332711,241047,,,,,0,5,332716,0,328694,,-4017,-4017,39337610.0,83102.0,6326628.0,6482645.0,98018.0,36409.0,-33109000.0,563795.0,83102.0,6482645.0,5882441.0,75102.0,,,32644.0,2132945.0,-1670000.0,1566229.0,166353.0,-1966592.0,-36409.0,-325219.0,,,,,6399543.0,en-US,US,EQUITY,False,Delayed Quote,USD,KYTO TECHNOLOGY AND LIFE SCI IN,0.039548043,19603660,3.1007752,15,America/New_York,EDT,-14400000,False,False,PRE,0,4,2.0,1629120610,0.0,2.0,2.0,2.0,3,PNK,us_market,0.0,2.0 - 2.0,2.0,finmb_3565490,Other OTC,"Kyto Technology and Life Science, Inc.",USD,1,0,0.25,0.14285715,1.75 - 2.0,0.0,0.0,1.75,2.0,-0.013,0.645,1.9342858,0.06571424,0.03397339,1.923913,0.076087,-0.21,,,2.0,1.75,1.9343,1.9239,1,,9.8M,,6.01M,55.03%,0.00%,,,,,,,,,,,0.00%,,,1:10,"Nov 03, 2015","Mar 30, 2020","Dec 30, 2020",0.00%,"27,095.21%",-11.87%,-1.86%,-3.29k,-0.00,-99.90%,14.15k,,-85.84k,-0.0130,,6.45M,0.66,8k,0.12,78.01,0.64,-2.46M,-299.04k,Value,94022,Financial Services,"Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in technology and life science companies. It does not lead financing transactions. The firm makes 50% investments in the United States and the remaining in Canada and Israel. KYTO Technology and Life Science, Inc. was formerly known as Kyto BioPharma, Inc. and changed its name in April 2018. Kyto Technology and Life Science, Inc. was founded in 1999 and is based in Los Altos Hills, California with an additional office in Scotts Valley, California.",Los Altos Hills,408-313-5830,CA,1609372800,United States,http://www.kytotech.com,86400,13050 La Paloma Road,Asset Management
t-1,KBPH,4165355.0,9801830,,,318137,,318137,63605,0,-160111,-160111,96506,,,,,0,0,160111,0,478248,,318137,318137,37211970.0,50459.0,4165355.0,4281190.0,58368.0,,-33104983.0,397442.0,50459.0,4281190.0,3883748.0,42459.0,,,12421.0,896000.0,-740000.0,1566229.0,271113.0,-874887.0,-36409.0,-465445.0,250000.0,250000.0,1000.0,,4230731.0,en-US,US,EQUITY,False,Delayed Quote,USD,KYTO TECHNOLOGY AND LIFE SCI IN,0.039548043,19603660,3.1007752,15,America/New_York,EDT,-14400000,False,False,PRE,0,4,2.0,1629120610,0.0,2.0,2.0,2.0,3,PNK,us_market,0.0,2.0 - 2.0,2.0,finmb_3565490,Other OTC,"Kyto Technology and Life Science, Inc.",USD,1,0,0.25,0.14285715,1.75 - 2.0,0.0,0.0,1.75,2.0,-0.013,0.645,1.9342858,0.06571424,0.03397339,1.923913,0.076087,-0.21,,,2.0,1.75,1.9343,1.9239,1,,9.8M,,6.01M,55.03%,0.00%,,,,,,,,,,,0.00%,,,1:10,"Nov 03, 2015","Mar 30, 2020","Dec 30, 2020",0.00%,"27,095.21%",-11.87%,-1.86%,-3.29k,-0.00,-99.90%,14.15k,,-85.84k,-0.0130,,6.45M,0.66,8k,0.12,78.01,0.64,-2.46M,-299.04k,Value,94022,Financial Services,"Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in technology and life science companies. It does not lead financing transactions. The firm makes 50% investments in the United States and the remaining in Canada and Israel. KYTO Technology and Life Science, Inc. was formerly known as Kyto BioPharma, Inc. and changed its name in April 2018. Kyto Technology and Life Science, Inc. was founded in 1999 and is based in Los Altos Hills, California with an additional office in Scotts Valley, California.",Los Altos Hills,408-313-5830,CA,1609372800,United States,http://www.kytotech.com,86400,13050 La Paloma Road,Asset Management
t-2,KBPH,2950602.0,9801830,,,-38868,,-38868,39368,500,-38868,-38868,96506,,,,,0,500,39368,0,0,,-38868,-38868,36315354.0,37037.0,2950602.0,3041828.0,58368.0,,-33423120.0,126329.0,37037.0,3041828.0,2915499.0,29037.0,,,2643.0,377250.0,-740000.0,1566229.0,92573.0,-34677.0,-36409.0,1048.0,-250000.0,-250000.0,2250.0,500.0,3004791.0,en-US,US,EQUITY,False,Delayed Quote,USD,KYTO TECHNOLOGY AND LIFE SCI IN,0.039548043,19603660,3.1007752,15,America/New_York,EDT,-14400000,False,False,PRE,0,4,2.0,1629120610,0.0,2.0,2.0,2.0,3,PNK,us_market,0.0,2.0 - 2.0,2.0,finmb_3565490,Other OTC,"Kyto Technology and Life Science, Inc.",USD,1,0,0.25,0.14285715,1.75 - 2.0,0.0,0.0,1.75,2.0,-0.013,0.645,1.9342858,0.06571424,0.03397339,1.923913,0.076087,-0.21,,,2.0,1.75,1.9343,1.9239,1,,9.8M,,6.01M,55.03%,0.00%,,,,,,,,,,,0.00%,,,1:10,"Nov 03, 2015","Mar 30, 2020","Dec 30, 2020",0.00%,"27,095.21%",-11.87%,-1.86%,-3.29k,-0.00,-99.90%,14.15k,,-85.84k,-0.0130,,6.45M,0.66,8k,0.12,78.01,0.64,-2.46M,-299.04k,Value,94022,Financial Services,"Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in technology and life science companies. It does not lead financing transactions. The firm makes 50% investments in the United States and the remaining in Canada and Israel. KYTO Technology and Life Science, Inc. was formerly known as Kyto BioPharma, Inc. and changed its name in April 2018. Kyto Technology and Life Science, Inc. was founded in 1999 and is based in Los Altos Hills, California with an additional office in Scotts Valley, California.",Los Altos Hills,408-313-5830,CA,1609372800,United States,http://www.kytotech.com,86400,13050 La Paloma Road,Asset Management
t-3,KBPH,2617485.0,9801830,,,-361097,,-361097,357297,-3800,-361097,-361097,96506,,,,,0,-3800,357297,0,0,,-361097,-361097,35943369.0,32144.0,2617485.0,2699755.0,58368.0,,-33384252.0,33756.0,32144.0,34256.0,,26394.0,2665499.0,500.0,-33853.0,172326.0,256174.0,1566229.0,-384942.0,-132268.0,-36409.0,1008.0,-425000.0,-425000.0,-2675.0,5500.0,2112.0,en-US,US,EQUITY,False,Delayed Quote,USD,KYTO TECHNOLOGY AND LIFE SCI IN,0.039548043,19603660,3.1007752,15,America/New_York,EDT,-14400000,False,False,PRE,0,4,2.0,1629120610,0.0,2.0,2.0,2.0,3,PNK,us_market,0.0,2.0 - 2.0,2.0,finmb_3565490,Other OTC,"Kyto Technology and Life Science, Inc.",USD,1,0,0.25,0.14285715,1.75 - 2.0,0.0,0.0,1.75,2.0,-0.013,0.645,1.9342858,0.06571424,0.03397339,1.923913,0.076087,-0.21,,,2.0,1.75,1.9343,1.9239,1,,9.8M,,6.01M,55.03%,0.00%,,,,,,,,,,,0.00%,,,1:10,"Nov 03, 2015","Mar 30, 2020","Dec 30, 2020",0.00%,"27,095.21%",-11.87%,-1.86%,-3.29k,-0.00,-99.90%,14.15k,,-85.84k,-0.0130,,6.45M,0.66,8k,0.12,78.01,0.64,-2.46M,-299.04k,Value,94022,Financial Services,"Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in technology and life science companies. It does not lead financing transactions. The firm makes 50% investments in the United States and the remaining in Canada and Israel. KYTO Technology and Life Science, Inc. was formerly known as Kyto BioPharma, Inc. and changed its name in April 2018. Kyto Technology and Life Science, Inc. was founded in 1999 and is based in Los Altos Hills, California with an additional office in Scotts Valley, California.",Los Altos Hills,408-313-5830,CA,1609372800,United States,http://www.kytotech.com,86400,13050 La Paloma Road,Asset Management
